Industry News
Related Searches:
Filter by:
1381 - 1395 of 2389 results
May 13, 2009
Eden Biodesign has completed a successful second audit by the UK Medicines and Healthcare Products Regulatory Agency (MHRA), European Medicines Agency (EMEA) to manufacture Investigational Medicinal Products (IMPs) at its facility in Liverpool, UK.
Read More »
May 12, 2009
Sanofi-aventis U.S. has acquired commercial rights to Oforta (fludarabine phosphate film-coated tablets), an oral B-cell chronic lymphocytic leukemia (CLL) drug, from biotechnology company Antisoma.
Read More »
May 12, 2009
Sartorius Stedim Biotech expanded its technology portfolio with the addition of two prototypes of single-use bioreactors that operate based on novel mixing technologies.
Read More »
May 8, 2009
ChemWerth entered a manufacturing partnership with Tianjin Tianyao Pharmaceuticals Co., Ltd., a China-based manufacturer and exporter of corticosteroid products.
Read More »
May 8, 2009
AAIPharma has acquired the Xcelodose 600S capsule filling system, enhancing the company’s preclinical and early phase clinical GMP supply capabilities.
Read More »
May 6, 2009
GlaxoSmithKline has entered into an agreement to divest full commercial rights to Wellbutrin XL in the U.S. to Biovail International Laboratories, for $510 million.
Read More »
May 4, 2009
Althea Technologies, Inc. has opened its new commercial-scale cGMP manufacturing facility in San Diego, CA.
Read More »
May 1, 2009
Lancaster Laboratories has been awarded the 2009 Eli Lilly Global Supplier Award for having a measurable impact on the company’s objectives and priorities.
Read More »
May 1, 2009
Novozymes Biopharma's Recombumin and albucult products are the first to comply with the new excipient monograph standard for recombinant human albumin, published in the U.S. Pharmacopoeia - National Formulary (USP-NF). First
Read More »
April 30, 2009
Amylin Pharmaceuticals and Lilly have agreed to the terms of a joint supply agreement for a pen device for exenatide once-weekly.
Read More »
April 29, 2009
ICON has acquired a 33,000-sq.-ft. Phase I facility in Omaha, NE from the former Qualia Clinical Services, Inc., with a capacity of as many as 100 beds.
Read More »
April 27, 2009
Patheon has signed agreements to commercialize two controlled release products utilizing OROS technology from its Cincinnati facility.
Read More »
April 27, 2009
Novozymes Biopharma has begun construction of a new cGMP facility at its existing site in Tianjin, China, enabling the company to produce Bacillus-based Hyaluronic Acid (bHA), HyaCare, for the bio-medical and pharmaceutical industries.
Read More »
April 21, 2009
Chiltern International Ltd. will acquire Vigiun, a full service CRO located in Sao Paulo, Brazil. Vigiun, established in 1999 by Eduardo Forleo, M.D., and Elisa Halker, BSN, has experience conducting clinical trials in a variety of therapeutic areas, incl
Read More »
April 20, 2009
GlaxoSmithKline and Stiefel Laboratories, Inc. have signed an agreement to create a new specialist dermatology business. Under the terms of the agreement, GSK will acquire Stiefel for $2.9 billion in cash with a potential further $0.3 billion cash payment
Read More »
1381 - 1395 of 2389 results
